Table 1.
Descriptive statistics of patients screened stratified by clinic location.
| Total (N = 668) | East (N = 13) | FMC LR (N = 6) | Internal medicine (N = 141) | North Central (N = 101) | Northeast (N = 234) | Northwest (N = 60) | Rahling (N = 15) | South Central (N = 31) | Southwest (N = 63) | West (N = 4) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | |||||||||||
| Male | 312 (47%) | 6 (46%) | 3 (50%) | 68 (48%) | 51 (50%) | 101 (43%) | 32 (53%) | 7 (47%) | 15 (48%) | 28 (44%) | 1 (25%) |
| Female | 356 (53%) | 7 (54%) | 3 (50%) | 73 (52%) | 50 (50%) | 133 (57%) | 28 (47%) | 8 (53%) | 16 (52%) | 35 (56%) | 3 (75%) |
| Age (years) | |||||||||||
| Mean (SD) | 56.15 (±13.29) | 52.85 (±16.86) | 61.33 (±6.802) | 57.45 (±12.56) | 61.51 (±13.00) | 53.31 (±12.86) | 57.73 (±13.74) | 53.27 (±12.03) | 51.39 (±14.43) | 57.05 (±11.61) | 53.00 (±28.66) |
| Ethnicity | |||||||||||
| American Indian | 4 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (1%) | 0 (0%) | 1 (7%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Asian | 9 (1%) | 0 (0%) | 0 (0%) | 2 (1%) | 3 (3%) | 0 (0%) | 2 (3%) | 0 (0%) | 0 (0%) | 1 (2%) | 1 (25%) |
| Black or African American | 221 (33%) | 10 (77%) | 3 (50%) | 85 (60%) | 3 (3%) | 61 (26%) | 4 (7%) | 7 (47%) | 24 (77%) | 24 (38%) | 0 (0%) |
| Hispanic or Latino | 24 (4%) | 0 (0%) | 0 (0%) | 3 (2%) | 3 (3%) | 7 (3%) | 11 (18%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Not on file | 31 (5%) | 1 (8%) | 0 (0%) | 0 (0%) | 6 (6%) | 20 (9%) | 1 (2%) | 1 (7%) | 0 (0%) | 2 (3%) | 0 (0%) |
| Other | 5 (1%) | 0 (0%) | 0 (0%) | 1 (1%) | 0 (0%) | 1 (0%) | 2 (3%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (25%) |
| White | 374 (56%) | 2 (15%) | 3 (50%) | 50 (35%) | 86 (85%) | 142 (61%) | 40 (67%) | 6 (40%) | 7 (23%) | 36 (57%) | 2 (50%) |
| Diabetic retinopathy | |||||||||||
| No | 541 (81%) | 7 (54%) | 5 (83%) | 113 (80%) | 86 (85%) | 194 (83%) | 50 (83%) | 11 (73%) | 22 (71%) | 49 (78%) | 4 (100%) |
| Yes | 104 (16%) | 3 (23%) | 1 (17%) | 26 (18%) | 12 (12%) | 34 (15%) | 7 (12%) | 4 (27%) | 8 (26%) | 9 (14%) | 0 (0%) |
| Undetermined | 23 (3.4%) | 3 (23.1%) | 0 (0%) | 2 (1.4%) | 3 (3.0%) | 6 (2.6%) | 3 (5.0%) | 0 (0%) | 1 (3.2%) | 5 (7.9%) | 0 (0%) |
| Diabetes | |||||||||||
| Type I | 21 (3%) | 2 (15%) | 0 (0%) | 4 (3%) | 1 (1%) | 7 (3%) | 1 (2%) | 0 (0%) | 3 (10%) | 2 (3%) | 1 (25%) |
| Type II | 647 (97%) | 11 (85%) | 6 (100%) | 137 (97%) | 100 (99%) | 227 (97%) | 59 (98%) | 15 (100%) | 28 (90%) | 61 (97%) | 3 (75%) |
| Insulin usage | |||||||||||
| No | 424 (63%) | 7 (54%) | 5 (83%) | 86 (61%) | 74 (73%) | 149 (64%) | 42 (70%) | 12 (80%) | 12 (39%) | 36 (57%) | 1 (25%) |
| Yes | 244 (37%) | 6 (46%) | 1 (17%) | 55 (39%) | 27 (27%) | 85 (36%) | 18 (30%) | 3 (20%) | 19 (61%) | 27 (43%) | 3 (75%) |
| Other pathology present | |||||||||||
| No | 423 (63%) | 7 (54%) | 5 (83%) | 78 (55%) | 68 (67%) | 159 (68%) | 40 (67%) | 6 (40%) | 20 (65%) | 39 (62%) | 1 (25%) |
| Yes | 245 (37%) | 6 (46%) | 1 (17%) | 63 (45%) | 33 (33%) | 75 (32%) | 20 (33%) | 9 (60%) | 11 (35%) | 24 (38%) | 3 (75%) |